Tequin (gatifloxacin), a new broad-spectrum quinolone

Bristol-Myers Squibb is now marketing Tequin (gatifloxacin), a new broad-spectrum quinolone...similar to Avelox and Levaquin.

All three are approved for community-acquired pneumonia...sinusitis...and acute exacerbations of chronic bronchitis.

Tequin will also be used for UTIs and uncomplicated gonorrhea.

Practical advice for a better career, with unlimited access to CE

Pharmacy Technician's Letter Canada includes:

  • 12 issues every year, with brief articles about new meds and hot topics
  • 120+ CE courses, including the popular CE-in-the-Letter
  • Helpful, in-depth Technician Tutorials
  • Access to the entire archive

Already a subscriber? Log in

Volume pricing available. Get a quote